Drug intelligence / Profile preview

Reepithol

Development stage
Unknown
Lead developer
Spey Medical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Topical
01

Overview

Reepithol (also referred to as Reepitol) is a topical wound-healing ointment containing 10% refined resin of the Norway spruce (*Picea abies*) as its active ingredient. Developed and marketed by SPEY and manufactured by HELP S.A., Reepithol is indicated for the local treatment of both infected and uninfected, acute and chronic skin wounds, including abrasions, skin cracks, burns, pressure sores (decubitus ulcers), diabetic foot ulcers, and surgical wound complications. The therapeutic efficacy of Norway spruce resin is derived from its complex mixture of resin acids (such as abietic, dehydroabietic, and pimaric acids) and lignans, which provide broad-spectrum antimicrobial, anti-inflammatory, and tissue-regenerative properties. Upon application, the ointment forms a protective physical barrier on the wound surface that prevents microbiological contamination, reduces local inflammation, and promotes re-epithelialization and tissue regeneration.

Brand names
AbilarReepitholReepitolSutriHeal Forte
Other names
Norway spruce resinPicea abies resinrefined resin of Norway spruce

Beyond the preview

Go deeper on Reepithol.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reepithol.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call